image
Healthcare - Biotechnology - NASDAQ - GB
$ 1.065
0.472 %
$ 37.4 M
Market Cap
-1.87
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-15.7 K OPERATING INCOME
99.88%
-16.8 M NET INCOME
-26.49%
EFFICIENCY
Earnings Waterfall OKYO Pharma Limited
image
Revenue 0
Cost Of Revenue 7.51 K
Gross Profit -7.51 K
Operating Expenses 8.24 K
Operating Income -15.7 K
Other Expenses 16.8 M
Net Income -16.8 M

Income Statement

Millions
Mar-2024 Mar-2023 Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016 Mar-2015 Mar-2014 Mar-2013 Mar-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008
REVENUE
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 7.51 K 3.8 K 2.42 K 13.1 K 5.97 K 219 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 7.51 K 3.8 K 2.42 K 13.1 K 5.97 K 219 0 0 0 0 0 0 0 0 0 0 0
OPERATING INCOME
Operating Expenses 8.24 K 13.2 6.2 3.4 1.5 4.5 1.0 0.4 1.1 1.8 4.8 4.7 5.4 1.7 (20.6) (15.1) 3.2
Selling, General and Administrative Expenses 0 6.7 4.9 3.0 1.0 1.9 0.6 0.4 1.0 1.7 4.6 4.7 0 1.61 K 4.52 K 63 K 73.4 K
Research and Development Expenses 8.24 K 6.3 1.6 0.3 0.5 3.0 0 0 0 0 0 0 0 0 0 0 0
Operating Income 15.7 K (13.2) (6.2) (4.1) (1.5) (4.5) (28.3) (0.4) (1.1) (1.8) (4.8) (4.7) (5.1) (1.7) 28.6 15.1 (3.2)
PRE-TAX INCOME
Interest Income Expense 1.1 96.7 K 0 1.12 K 1.16 K 0 0 0 0 0 4.14 K 0 0 0 0 0 0
Total Other Income 1.05 K 96.7 K 0 0.8 99.5 K (0.4) 12.4 K 0.1 96 K 0 (9.2) 64.4 K (0.6) 0 0 0 0
Pre-Tax Income 16.8 K (13.3) (6.2) (3.4) (1.6) (4.9) (28.3) (0.2) (1.0) (1.5) (13.9) (4.7) (5.7) (1.6) 12.7 14.3 (3.0)
NET INCOME
Tax Provision 22.4 12.2 K (0.8) 25 K 76.2 K (0.2) 0.83 56.9 K (0.2) 6.8 4.14 K 0.019 (0.9) 0 0 0 0
Net Income 16.8 K (13.3) (5.4) (3.4) (1.5) (4.9) (28.3) (0.2) (0.8) (8.3) (13.9) (4.7) (4.8) (1.6) 12.7 14.3 (3.0)
EPS 0.0006 0.6 0.0055 0.005 0.0026 0.0095 0.0738 0.0006 0.0022 0.0219 0.0463 0.0164 0.0186 0.0046 0.0377 0.0444 0.0534